Jump to content

Diphenidol: Difference between revisions

Page 1
Page 2
Content deleted Content added
Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'DrugBank').
Synthesis section
 
(41 intermediate revisions by 27 users not shown)
Line 1: Line 1:
{{Short description|Antiemetic and antivertigo drug}}
{{Drugbox
{{Drugbox
| verifiedrevid = 443694894
| verifiedrevid = 458630923
| IUPAC_name = 1,1-di(phenyl)-4-piperidin-1-ylbutan-1-ol
| IUPAC_name = 1,1-di(phenyl)-4-piperidin-1-ylbutan-1-ol
| image = Diphenidol.svg
| image = Diphenidol.svg

<!--Clinical data-->
<!--Clinical data-->
| tradename =
| tradename =
Line 16: Line 16:
| legal_status =
| legal_status =
| routes_of_administration = Oral
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
<!--Pharmacokinetic data-->
| bioavailability =
| bioavailability =
Line 23: Line 22:
| elimination_half-life = 4 hours
| elimination_half-life = 4 hours
| excretion =
| excretion =

<!--Identifiers-->
<!--Identifiers-->
| IUPHAR_ligand = 7163
| CASNo_Ref = {{cascite|correct|CAS}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 972-02-1
| CAS_number = 972-02-1
Line 44: Line 42:
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 936
| ChEMBL = 936

<!--Chemical data-->
<!--Chemical data-->
| C=21 | H=27 | N=1 | O=1
| C=21 | H=27 | N=1 | O=1
| molecular_weight = 309.44518 g/mol
| smiles = OC(c1ccccc1)(c2ccccc2)CCCN3CCCCC3
| smiles = OC(c1ccccc1)(c2ccccc2)CCCN3CCCCC3
| InChI = 1/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2
| InChIKey = OGAKLTJNUQRZJU-UHFFFAOYAI
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2
| StdInChI = 1S/C21H27NO/c23-21(19-11-4-1-5-12-19,20-13-6-2-7-14-20)15-10-18-22-16-8-3-9-17-22/h1-2,4-7,11-14,23H,3,8-10,15-18H2
Line 56: Line 50:
| StdInChIKey = OGAKLTJNUQRZJU-UHFFFAOYSA-N
| StdInChIKey = OGAKLTJNUQRZJU-UHFFFAOYSA-N
}}
}}
'''Diphenidol''' is an [[muscarinic antagonist]] employed as an [[antiemetic]] and as an anti[[Vertigo (medical)|vertigo]] agent. It is currently not marketed in the United States or Canada.
'''Diphenidol''' is a [[muscarinic antagonist]] employed as an [[antiemetic]] and as an anti[[Vertigo (medical)|vertigo]] agent. It is not marketed in the United States or Canada.


Although the mechanism of action of diphenidol on the [[vestibular system]] has not yet been elucidated, it exerts an [[anticholinergic]] effect due to interactions with [[Muscarinic receptor|mACh receptor]]s, particularly M<sub>1</sub>, M<sub>2</sub>, M<sub>3</sub> and M<sub>4</sub>. Hence, its actions may take place at the vestibular nuclei, where a significant excitatory input is mediated by ACh receptors, and also at the vestibular periphery where mACh receptors are expressed at efferent synapses. A series of selective mACh-receptor antagonists based on the diphenidol molecule has been synthesized, but they have not yet been the subject of clinical trials.<ref>{{cite journal | vauthors = Soto E, Vega R | title = Neuropharmacology of vestibular system disorders | journal = Current Neuropharmacology | volume = 8 | issue = 1 | pages = 26–40 | date = March 2010 | pmid = 20808544 | pmc = 2866460 | doi = 10.2174/157015910790909511 }}</ref>
==References==
==Synthesis==
DrugBank http://www.drugbank.ca/drugs/DB01231
[[File:Diphenidol synthesis.svg|thumb|center|500px|Synthesis:<ref>Katz, Leon; Karger, Lawrence S. (1952). "The Mannich Reaction on α,α-Diphenylacetone". Journal of the American Chemical Society. 74 (16): 4085–4086. doi:10.1021/ja01136a034.</ref><ref>Gautier, J.A. et al, Bull. Soc. Chim. Fr., 1964, 2145.</ref><ref>Marxer, A. (1941). "Grignard-Reaktionen mit Halogen-alkyl-aminen". Helvetica Chimica Acta. 24 (2): 209E–225E. doi:10.1002/hlca.19410240225.</ref><ref>Vitale, Arturo A.; Doctorovich, F.; Sbarbati Nudelman, N. (1987). "One-pot synthesis of diarylalkylcarbinols and substituted derivatives through carbon monoxide insertion reactions into aryllithiums". Journal of Organometallic Chemistry. 332 (1-2): 9–18. doi:10.1016/0022-328X(87)85117-3.</ref> 10%:<ref>Schmidt, Andreas; Marchetti, Mauro; Eilbracht, Peter (2004). "Regioselective hydroaminomethylation of 1,1-diaryl-allyl-alcohols: a new access to 4,4-diarylbutylamines". Tetrahedron. 60 (50): 11487–11492. doi:10.1016/j.tet.2004.09.058.</ref> Patents:<ref>Marxer Adrian, Miescher Karl, {{US patent|2411664}} (1946 to Ciba Pharmaccutical Products I).</ref><ref>Barrett Paul Anthony & Wilkinson Samuel, GB683950 (1952 to Wellcome Found).</ref><ref>, BE620404 (1961 to SKF Labs).</ref>]]
<references/>
Alkylation of [[1-Bromo-3-chloropropane]] [109-70-6] ('''1''') with [[piperidine]] ('''2''') gives 3-Piperidinopropyl chloride [1458-63-5] ('''3'''). The Grignard reaction of this intermediate with benzophenone [119-61-9] gives the benzhydrol and hence, Diphenidol ('''4''').

== References ==

{{reflist}}

{{Uncategorized|date=November 2011}}


[[Category:Antiemetics]]


{{pharmacology-stub}}
{{pharmacology-stub}}

[[ja:ジフェニドール]]